William Blair Has Positive Outlook of HURN FY2025 Earnings

Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) - William Blair increased their FY2025 earnings per share estimates for Huron Consulting Group in a research note issued on Wednesday, April 30th. William Blair analyst A. Nicholas now expects that the business services provider will post earnings per share of $7.50 for the year, up from their prior forecast of $7.09. William Blair has a "Outperform" rating on the stock. The consensus estimate for Huron Consulting Group's current full-year earnings is $6.10 per share. William Blair also issued estimates for Huron Consulting Group's Q1 2026 earnings at $1.32 EPS, Q2 2026 earnings at $2.11 EPS, Q3 2026 earnings at $2.40 EPS, Q4 2026 earnings at $2.33 EPS and FY2026 earnings at $8.15 EPS.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last posted its earnings results on Tuesday, April 29th. The business services provider reported $1.68 EPS for the quarter, topping analysts' consensus estimates of $1.16 by $0.52. The business had revenue of $404.14 million during the quarter, compared to analyst estimates of $389.27 million. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. The company's quarterly revenue was up 11.2% compared to the same quarter last year. During the same quarter last year, the company earned $1.23 EPS.

Several other analysts also recently issued reports on the company. Barrington Research reissued an "outperform" rating and set a $167.00 target price on shares of Huron Consulting Group in a research note on Thursday, March 27th. Wedbush lifted their price target on shares of Huron Consulting Group from $150.00 to $165.00 and gave the company an "outperform" rating in a report on Wednesday, March 26th. Benchmark restated a "buy" rating and set a $165.00 price objective on shares of Huron Consulting Group in a research report on Wednesday, March 26th. Truist Financial boosted their target price on Huron Consulting Group from $165.00 to $180.00 and gave the stock a "buy" rating in a research report on Tuesday, March 4th. Finally, StockNews.com cut shares of Huron Consulting Group from a "buy" rating to a "hold" rating in a research report on Friday. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $169.25.

Huron Consulting Group Stock Performance

Shares of NASDAQ HURN traded up $6.44 during trading on Thursday, hitting $147.36. The company had a trading volume of 341,310 shares, compared to its average volume of 147,810. Huron Consulting Group has a 12 month low of $84.87 and a 12 month high of $153.85. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.61 and a current ratio of 1.61. The firm has a market capitalization of $2.64 billion, a P/E ratio of 32.03 and a beta of 0.37. The stock has a 50 day simple moving average of $143.09 and a 200 day simple moving average of $129.80.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Heck Capital Advisors LLC purchased a new stake in shares of Huron Consulting Group in the 4th quarter valued at approximately $33,000. Opal Wealth Advisors LLC acquired a new stake in shares of Huron Consulting Group during the 1st quarter worth about $35,000. CWM LLC lifted its stake in Huron Consulting Group by 55.9% during the first quarter. CWM LLC now owns 407 shares of the business services provider's stock worth $58,000 after purchasing an additional 146 shares during the last quarter. Tower Research Capital LLC TRC boosted its holdings in Huron Consulting Group by 27.3% in the fourth quarter. Tower Research Capital LLC TRC now owns 569 shares of the business services provider's stock valued at $71,000 after purchasing an additional 122 shares in the last quarter. Finally, USA Financial Formulas purchased a new position in Huron Consulting Group in the first quarter valued at approximately $114,000. 93.90% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director John Mccartney sold 500 shares of the business's stock in a transaction dated Tuesday, April 1st. The shares were sold at an average price of $142.67, for a total transaction of $71,335.00. Following the transaction, the director now owns 52,121 shares of the company's stock, valued at approximately $7,436,103.07. The trade was a 0.95 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director H Eugene Lockhart sold 1,042 shares of the stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $125.15, for a total value of $130,406.30. Following the completion of the transaction, the director now owns 24,672 shares of the company's stock, valued at $3,087,700.80. The trade was a 4.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 78,781 shares of company stock worth $11,484,452. 2.15% of the stock is owned by corporate insiders.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.